Connect with us
Grifols closed 2021 with a profit of $192 million (€182.3 million), compared with the $651 million (€618.5 million) recorded in 2020. Grifols recorded a turnover of...
Microviable Therapeutics emerged as a spin-off from Ipla-Csic in 2016, focused on the development of technologies and therapeutic products derived from the microbiota. Microviable Therapeutics will...
At the Madrid center, Peaches Biotech is developing a bio incubator focused on research and innovation (R&D) and aims to promote translational projects in the areas...
The president of Atrys Health gave a positive assessment of the 2021 financial year, in which the company launched the takeover bid for Aspy, various acquisitions...
In ten years since its inception, Moderna has transformed from a research-stage company advancing programs in the messenger RNA (mRNA) field to a company with a...
The Spanish biotech company AcceXible has recently entered the market in Colombia. AcceXible expects to have a turnover of $491,000 (€450,000) in 2022. The company received...
Moderna closed 2021 with a profit of $12.2 billion, compared to a loss of $747 million recorded in 2020. Moderna's total revenue in 2021 was $18.471...
For the time being, Devicare is launching this product in the Netherlands. At the beginning of 2021, Devicare closed a financing round of $3 million. The...
GenesisCare has more than 350 oncology centers around the world. The works have meant a great qualitative leap forward, equipping the Alcázar de San Juan center...
The six listed pharmaceutical companies close the first quarter of 2022 with a stock market value of $16.7 billion (€15.1 billion). The biggest decline was registered...
 |
|
 |  |
 |
|